These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38235005)

  • 21. India Unburdening the Pandemic: Jabs and Talks.
    Basu E; Raj MP; Krishnamurthy V
    Cureus; 2023 Jun; 15(6):e40991. PubMed ID: 37503498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccinating a billion people against COVID-19: India's quest for systems leadership in exceptional times.
    Gulati K; Busari J
    Leadersh Health Serv (Bradf Engl); 2021 Nov; ahead-of-print(ahead-of-print):. PubMed ID: 34787981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World's Biggest COVID-19 Vaccination Campaign.
    Koller CN; Schwerzmann CJ; Lang ASA; Alexiou E; Krishnakumar J
    Epidemiologia (Basel); 2021 Sep; 2(3):454-470. PubMed ID: 36417236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human health implications of emerging diseases and the current situation in India's vaccine industry.
    Behera JK; Mishra P; Jena AK; Behera B; Bhattacharya M
    Sci One Health; 2023; 2():100046. PubMed ID: 39077045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health diplomacy in Africa-opportunities post-COVID-19.
    Boujnah H
    Pan Afr Med J; 2022; 43():91. PubMed ID: 36660083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic geographies and access to medicines: Tracing the role of India's pharmaceutical industry in global trade.
    Bjerke L
    Soc Sci Med; 2022 Nov; 312():115386. PubMed ID: 36182675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic treaty as an instrument to strengthen global health security: Global health diplomacy at its crux.
    Chattu VK; Mol R; Singh B; Reddy KS; Hatefi A
    Health Promot Perspect; 2024 Mar; 14(1):9-18. PubMed ID: 38623344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aiding Universal Health Coverage through Humanitarian Outreach Services and Global Health Diplomacy in Resource-Poor Settings.
    Chattu VK; Jean-Louis G; Zeller JL; Pandi-Perumal SR
    J Natl Med Assoc; 2021 Feb; 113(1):102-104. PubMed ID: 32861434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indian Biosimilars and Vaccines at Crossroads-Replicating the Success of Pharmagenerics.
    Panda S; Singh PK; Mishra S; Mitra S; Pattnaik P; Adhikary SD; Mohapatra RK
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capacity building for global health diplomacy: Thailand's experience of trade and health.
    Thaiprayoon S; Smith R
    Health Policy Plan; 2015 Nov; 30(9):1118-28. PubMed ID: 25339636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rethinking and strengthening the Global Health Diplomacy through triangulated nexus between policy makers, scientists and the community in light of COVID-19 global crisis.
    AlKhaldi M; James N; Chattu VK; Ahmed S; Meghari H; Kaiser K; IJsselmuiden C; Tanner M
    Glob Health Res Policy; 2021 Apr; 6(1):12. PubMed ID: 33845923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closing the Gap Between Emerging Initiatives and Integrated Strategies to Strengthen Science Diplomacy in Latin America.
    López-Vergès S; Macías-Navarro L; Hernández-Mondragón AC; Corrales-Aguilar E; Soler MG; Guerra M
    Front Res Metr Anal; 2021; 6():664880. PubMed ID: 33912788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. India's Decision to Deny an Extension of Patent for Bedaquiline: A Public Health Imperative.
    Yadav S; Rawal G; Jeyaraman M
    Cureus; 2023 Nov; 15(11):e49542. PubMed ID: 38156185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rise of global health diplomacy: An interdisciplinary concept linking health and international relations.
    Chattu VK
    Indian J Public Health; 2017; 61(2):134-136. PubMed ID: 28721965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Covishield and Covaxin" - India's contribution to global COVID-19 pandemic.
    Raina SK; Kumar R
    J Family Med Prim Care; 2021 Jul; 10(7):2433-2435. PubMed ID: 34568116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping 'consistency' in India's climate change position: Dynamics and dilemmas of science diplomacy.
    Gupta H; Kohli RK; Ahluwalia AS
    Ambio; 2015 Oct; 44(6):592-9. PubMed ID: 25567075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correcting India's Chronic Shortage of Drug Inspectors to Ensure the Production and Distribution of Safe, High-Quality Medicines.
    Kadam AB; Maigetter K; Jeffery R; Mistry NF; Weiss MG; Pollock AM
    Int J Health Policy Manag; 2016 Sep; 5(9):535-542. PubMed ID: 27694680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. India's Frantic Fight Against COVID-19: Rescuing a Broken Healthcare System by Adopting a "Doctor and Patient First" Approach.
    Baqal OJ; Farouk AF
    Pak J Med Sci; 2022; 38(4Part-II):1064-1066. PubMed ID: 35634628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.
    Setayesh S; Mackey TK
    Global Health; 2016 Jun; 12(1):31. PubMed ID: 27267898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.